Read the full interview:
TOPADUR announced that Pascal Brenneisen has been appointed CEO, effective April 1, 2023, on top of his Board member assignment.
Read moreThe Switzerland Global Enterprise interviewed Reto Naef, CEO of TOPADUR PHARMA AG.
Read moreTOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds.
Read more